Dr. Abram Soliman, MD

NPI: 1962082545
Total Payments
$1,532
2024 Payments
$1,031
Companies
11
Transactions
15

Payment Breakdown by Category

Food & Beverage$1,532 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,532 15 100.0%

Top Paying Companies

Company Total Records Latest Year
UCB, Inc. $273.70 3 $0 (2024)
AstraZeneca Pharmaceuticals LP $162.27 3 $0 (2024)
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $140.57 1 $0 (2024)
Mallinckrodt Hospital Products Inc. $124.76 1 $0 (2024)
Alexion Pharmaceuticals, Inc. $123.03 1 $0 (2024)
ABBVIE INC. $121.91 1 $0 (2024)
ARGENX US, INC. $121.84 1 $0 (2024)
Novo Nordisk Inc $121.84 1 $0 (2024)
E.R. Squibb & Sons, L.L.C. $119.82 1 $0 (2023)
Amylyx Pharmaceuticals, Inc. $118.23 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,031 9 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($140.57)
2023 $501.02 6 UCB, Inc. ($231.51)

All Payment Transactions

15 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/18/2024 UCB, Inc. Zilbrysq (Drug) Food and Beverage In-kind items and services $42.19 General
Category: Neurology
10/09/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $121.84 General
Category: Obesity
09/03/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $140.57 General
Category: Electromedical and Electrotherapeutic Apparatus
08/07/2024 ARGENX US, INC. VYVGART (Drug) Food and Beverage In-kind items and services $121.84 General
Category: Immunology
07/25/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $124.76 General
Category: CRITICAL CARE
05/07/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $123.03 General
Category: Rare Disease
03/12/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $116.75 General
Category: Cardiovascular and Metabolism
02/20/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $121.91 General
Category: NEUROSCIENCE
02/07/2024 Amylyx Pharmaceuticals, Inc. RELYVRIO (Drug) Food and Beverage In-kind items and services $118.23 General
Category: NEUROLOGY
11/07/2023 Grifols USA, LLC Gamunex-C (Biological) Food and Beverage In-kind items and services $104.17 General
Category: Immunology and Neurology
10/26/2023 UCB, Inc. Food and Beverage In-kind items and services $125.00 General
09/28/2023 UCB, Inc. Food and Beverage In-kind items and services $106.51 General
08/10/2023 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $119.82 General
Category: Cardiovascular
03/16/2023 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $22.76 General
Category: Oncology
03/10/2023 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $22.76 General
Category: Oncology

About Dr. Abram Soliman, MD

Dr. Abram Soliman, MD is a Hospitalist healthcare provider based in Cathedral City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2021. The National Provider Identifier (NPI) number assigned to this provider is 1962082545.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abram Soliman, MD has received a total of $1,532 in payments from pharmaceutical and medical device companies, with $1,031 received in 2024. These payments were reported across 15 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,532).

Practice Information

  • Specialty Hospitalist
  • Other Specialties Internal Medicine
  • Location Cathedral City, CA
  • Active Since 04/08/2021
  • Last Updated 07/03/2024
  • Taxonomy Code 208M00000X
  • Entity Type Individual
  • NPI Number 1962082545

Products in Payments

  • LifeVest (Device) $140.57
  • TERLIVAZ (Drug) $124.76
  • ULTOMIRIS (Biological) $123.03
  • QULIPTA (Drug) $121.91
  • VYVGART (Drug) $121.84
  • Wegovy (Drug) $121.84
  • ELIQUIS (Drug) $119.82
  • RELYVRIO (Drug) $118.23
  • FARXIGA (Drug) $116.75
  • Gamunex-C (Biological) $104.17
  • CALQUENCE (Drug) $45.52
  • Zilbrysq (Drug) $42.19

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hospitalist Doctors in Cathedral City